Bipolar Disorder

How does psychiatry access differ among patients, and how should it become individualized?

Bipolar depression can be difficult to treat and is often misdiagnosed.

A new set of 22 recommendations include a combination of universal screenings, medication, and other preventative initiatives in an effort to drive down veteran suicide rates.

In a comprehensive new study, investigators discover unique patterns in the brains of both family members and patients with psychotic disorders, including bipolar disorder and schizophrenia.

In an extensive population-based study, investigators link children with IBD with an increased risk of any psychiatric disorder.

A new study looks at the links between ADHD and bipolar disorder in children and adolescents.

This week's #DocTalk tweet chat generated discussion on the means by which healthcare professionals can influence mental health policies and understanding.

Allergan announced the FDA approved a New Drug Application for Vraylar for the treatment of depressive episodes associated with bipolar depression.

Investigators presented data from a 2-year, open-label study into the efficacy and safety of lurasidone in children 10 to 17 years old at APA 2019.

The antipsyhoctic could receive a new indication in 2019, and though the field of bipolar disorder care is far from perfect, it should improve with this addition.

The study focused on patients with bipolar or depressive disorder.

A retrospective study showed which patients with substance use disorder may have less successful antiepileptic drug treatment.

Most of the patients in the study were taking concomitant antidepressants and/or antipsychotics, and mood disorders remained stable during treatment with valbenazine.

Tardive dyskinesia due to lithium treatment is still rare, but the antipsyhotic therapy substitute was linked to at least 1 particular patient case.

People with depression exhibit an unexpected increase in volume on the left side of the hypothalamus, the brain region responsible for physical wellbeing.

Meeting with a peer support worker to complete a personal recovery workbook reduced readmissions over a year for patients with mental health challenges.

People living with mental illness face great adversity. One of their greatest challenges is the seemingly intractable problem of stigma.

Response to ketamine treatment in mood disorders may be better predicted based on baseline cognitive impairment.

The agency warns that the seizure and bipolar disorder medication can cause hemophagocytic lymphohistiocytosis, a rare but very serious immune system reaction.

Women with PCOS face increased risk of psychiatric morbidity and their children are more likely to be diagnosed with ADHD or autism.

Two phase 3 clinical trials begin enrollment for treatment of manic episodes associated with bipolar I disorder.

Positive results showed 6 weeks of treatment associated with significant improvement of depressive symptoms in children and adolescents.

Dr. Kiki Chang sits down with MD Magazine and talks about the latest data on lurasidone.

Patients with colorectal cancer are at a higher risk for mood disorders.

Adults diagnosed with bipolar disorder are much more likely than the general population to have suffered emotional, physical, or sexual abuse as children.